Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial-Reference-Cited by-同舟云学术

Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial

Published:2014-07 Issue:7 Volume:32 Page:1478-1487
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Beckett Nigel,Peters Ruth,Leonetti Gastone,Duggan Joe,Fagard Robert,Thijs Lut,Narkiewicz Krzysztof,McCormack Terry,Banya Winston,Fletcher Astrid,Bulpitt Christopher

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference14 articles.

1. Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.;Bulpitt;Drugs Aging,2001

2. Treatment of hypertension in patients 80 years of age or older.;Beckett;N Engl J Med,2008

3. J H;ypertens,1999

4. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).;Mancia;J Hypertens,2007

5. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group.;Gueyffier;Lancet,1999

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension;European Heart Journal;2024-08-30

2. Hypertension-mediated organ damage involving multiple sites is an independent risk factor for cardiovascular events;European Heart Journal Open;2023-09

3. Renal denervation for resistant hypertension and heart failure with a reduced ejection fraction;Annals of Clinical Hypertension;2023-03-16

4. Cognitive dysfunctions in patients with hypertension — pathogenesis and treatment;Arterial Hypertension;2022-06-30

5. Do recent meta-analyses truly prove that treatment with blood pressure-lowering drugs is beneficial at any blood pressure value, no matter how low? A critical review;Journal of Hypertension;2022-02-21